Cumberland Valley Retina Consultants,P.C. — Hagerstown, Maryland

Cumberland Valley Retina Consultants,P.C. is a clinical research site located in Hagerstown, Maryland, United States 21740.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Cumberland Valley Retina Consultants,P.C. has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Geographic Atrophy, Macular Degeneration, Neovascular Age-related Macular Degeneration.

Sponsors: Astellas Pharma Global Development, Inc., Sitala Bio LTD, Allergan.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hagerstown

Browse all research sites in Maryland · View every site in Hagerstown

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cumberland Valley Retina Consultants,P.C.?

Cumberland Valley Retina Consultants,P.C. has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cumberland Valley Retina Consultants,P.C. conducted?

Cumberland Valley Retina Consultants,P.C. has 6 clinical trials on record, with 3 currently active. Their work covers Geographic Atrophy, Macular Degeneration, Neovascular Age-related Macular Degeneration.

Is Cumberland Valley Retina Consultants,P.C. accredited by Crixeo Clinical Trials?

Cumberland Valley Retina Consultants,P.C. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cumberland Valley Retina Consultants,P.C.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.